BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3476226)

  • 1. HLA and survival in lung cancer.
    Mottironi VD; Banks SM; Pollara B; Rudofsky UH
    Clin Immunol Immunopathol; 1987 Oct; 45(1):55-62. PubMed ID: 3476226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histocompatibility locus antigens (HLA) in the epidermoid type of lung carcinoma.
    Prazák J; Mĕricka O; Chytrý J
    J Cancer Res Clin Oncol; 1990; 116(5):525-7. PubMed ID: 2229145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antigens and bronchogenic carcinoma.
    Prazák J; Mĕricka O
    Neoplasma; 1989; 36(5):599-602. PubMed ID: 2812153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA frequency and prognosis in lung cancer.
    Ford CH; Newman CE; Mackintosh P
    Br J Cancer; 1981 May; 43(5):610-4. PubMed ID: 6264939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA antigens and bronchogenic carcinoma in the Greek population.
    Toumbis M; Zervas J; Anagnostopoulou O; Konstantopoulos K; Krimbeni G; Kotsovoulou V; Fessas F
    Acta Oncol; 1991; 30(5):575-8. PubMed ID: 1654063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association between HLA antigens and adenocarcinoma of the lung in non-smoking Chinese women in Hong Kong.
    Lam WK; Hawkins BR; Kung IT; So SY
    Br J Dis Chest; 1986 Oct; 80(4):370-4. PubMed ID: 3476147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HLA-A, B antigens and bronchogenic pulmonary carcinoma].
    Prazák J; Mĕricka O
    Cas Lek Cesk; 1987 Aug; 126(34):1081-2. PubMed ID: 3478139
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.
    Nissen MH; Plesner T; Larsen JK; Olesen BK; Ernst P
    Clin Exp Immunol; 1985 Feb; 59(2):327-35. PubMed ID: 2983911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged disease-free survival in bronchogenic carcinoma associated with HLA-Aw19 and HLA-B5. A two-year prospective study.
    Rogentine CN; Dellon AL; Chretien PB
    Cancer; 1977 Jun; 39(6):2345-7. PubMed ID: 872033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of HLA in patients with glioma].
    Takai N; Yoshida S; Hara N; Saito T; Kamoya K; Tanaka R
    No To Shinkei; 1986 Aug; 38(8):741-5. PubMed ID: 3464315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA phenotypes in Mexican Americans with tuberculosis.
    Cox RA; Arnold DR; Cook D; Lundberg DI
    Am Rev Respir Dis; 1982 Oct; 126(4):653-5. PubMed ID: 6957158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.
    Doyle A; Martin WJ; Funa K; Gazdar A; Carney D; Martin SE; Linnoila I; Cuttitta F; Mulshine J; Bunn P
    J Exp Med; 1985 May; 161(5):1135-51. PubMed ID: 2580935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA frequencies in the Indian population of Johannesburg.
    Wadee AA; du Toit ED
    S Afr Med J; 1989 Oct; 76(7):331-4. PubMed ID: 2799579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of human leukocyte antigens in patients with internal derangement of the temporomandibular joint.
    Henry CH; Nikaein A; Wolford LM
    J Oral Maxillofac Surg; 2002 Jul; 60(7):778-83. PubMed ID: 12089692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frequency of HLA-A, HLA-B and HLA-Cw antigens in the Slovak population].
    Kralovicova J; Kusikova M; Buc M; Holomanova D; Sakalova A
    Bratisl Lek Listy; 2000; 101(1):24-7. PubMed ID: 10824408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigens as genetic markers in colorectal carcinoma.
    Chatzipetrou MA; Tarassi KE; Konstadoulakis MM; Pappas HE; Zafirellis KD; Athanassiades TE; Papadopoulos SA; Panousopoulos DG; Golematis BC; Papasteriades CA
    Dis Colon Rectum; 1999 Jan; 42(1):66-70. PubMed ID: 10211522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological and biochemical identification of HLA-Aw33 subtypes.
    de Waal LP; Mesman HJ; Engelfriet CP
    Immunogenetics; 1987; 26(4-5):211-5. PubMed ID: 3653938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA and prognostic factors in primary breast cancer.
    Iaffaioli RV; Maio M; Ruggiero G; De Felice M; Ungaro A; Del Vecchio L; Rosato GB; Bianco AR; Zappacosta S
    Int J Cancer; 1985 May; 35(5):581-5. PubMed ID: 3873417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA antigen frequency in granuloma annulare.
    Middleton D; Allen GE
    Br J Dermatol; 1984 Jan; 110(1):57-9. PubMed ID: 6691918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA antigens in patients with otosclerosis.
    Dahlqvist A; Diamant H; Dahlqvist SR; Cedergren B
    Acta Otolaryngol; 1985; 100(1-2):33-5. PubMed ID: 3861067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.